The Wacker chemical group has acquired contract manufacturing company (CMO) ADL BioPharma for approximately €100 million.
Wacker says it is buying a large-scale fermentation facility in Spain to support growing demand for the amino acid cysteine.
ADL BioPharma News Full Screen View
Market Place
Share